The CCAAT/enhancer binding proteins (C/EBPs) are members of the basic region -leucine zipper (bZIP) class of transcription factors and play important roles in fundamental cellular processes including proliferation, growth arrest, and differentiation in a cell-type specific manner. Mice deficient in any of the six members of the C/EBP family (C/EBPa, C/EBPb, C/EBPg, C/EBPd, C/EBPe, and C/EBPz) each exhibit unique phenotypes. Of these, the null mutation of C/EBPb confers by far the most phenotypes by affecting diverse cell types and a multitude of functions in many different organs. For example, C/EBPb is involved in innate and acquired immunity, and differentiation of mammary epithelial cells, adipocytes, ovarian granulosa cells, and epidermal keratinocytes (Ramji and Foka, 2002) .
C/EBPb is implicated in cell transformation/tumor formation in several cell types/tissues. For example, C/EBPb can cooperate with Ras to transform NIH 3T3 cells in a phosphorylation-dependent manner (Zhu et al., 2002; Shuman et al., 2004) . The C/EBPb gene expresses three different isoforms by virtue of alternative translation initiation or regulated proteolysis (Ramji and Foka, 2002) . Human C/EBPb-2 (comparable to the major form expressed in mouse) expression is increased in breast cancer cell lines and primary breast tumors (Bundy and Sealy, 2003) . Moreover, overexpression of C/EBPb-2 in a human mammary epithelial cell line lead to anchorage independence and invasive properties (Bundy and Sealy, 2003) . C/EBPb is highly expressed in colorectal tumors (Rask et al., 2000) and is associated with ovarian tumor progression (Sundfeldt et al., 1999) . Furthermore, C/EBPb can interact with cyclin D1 and appears to be important for the unique pattern of altered gene expression in human cancers that overexpress cyclin D1 (Lamb et al., 2003) .
C/EBPb is abundantly expressed in keratinocytes (Oh and Smart, 1998) and we previously reported that C/EBPb À/À mice are completely refractory to skin tumorigenesis induced by carcinogens, such as 7,12-dimethylbenz[a]anthracene (DMBA), that produce oncogenic Ras mutations in epidermal keratinocytes (Zhu et al., 2002) . C/EBPb À/À mice also display elevated levels of DMBA-induced apoptosis suggesting that C/EBPb has a role in keratinocyte survival in response to oncogenic Ras signaling and/or DNA damage (Zhu et al., 2002; Johnson, 2005) . These data demonstrate an important role for C/EBPb in keratinocytes survival and skin tumorigenesis. However, phenotypes of germline knockouts can be complicated by pleiotropic effects of the protein under study in various tissues and organs (Lewandoski, 2001) . For example, germline deletion of Rb results in severe defects in neurogenesis involving increased apoptosis. Subsequent studies have shown that the apoptosis in the CNS is due to a nonautonomous neuronal defect (de Bruin et al., 2003; MacPherson et al., 2003) . As C/EBPb is implicated in the regulation of many different molecular and physiological processes, it is possible that systemic factors are involved in the increased keratinocyte apoptosis as well as the subsequent lack of skin tumorigenesis in carcinogen treated C/EBPb À/À mice. C/EBPb null mice (C/EBPb À/À ) have major defects in their immune system (Screpanti et al., 1995; Tanaka et al., 1995) and C/EBPb is known to be involved in the regulation of numerous cytokines (Poli, 1998) some of which are important in Ras-tumorigenesis (Sparmann and Bar-Sagi, 2005) . It is a distinct possibility that the increase in epidermal keratinocyte apoptosis in DMBA-treated C/EBPb À/À mice and subsequent lack of tumor development could be of a systemic nature, perhaps involving alterations in the expression of nonkeratinocyte-derived cytokines. In addition, C/EBPb activity is implicated in a number of conditions that are known to affect skin tumorigensis through systemic mechanisms, such as metabolic status (Boutwell, 1983) , cytokine and growth factor expression (Klatt and Serrano, 2003) , and steroid hormone levels (Porter et al., 2002) . Thus, it is critical to determine the contribution of systemic versus keratinocyte autonomous functions of C/EBPb in skin tumorigenesis.
To this aim, we generated a conditional null allele of C/EBPb by flanking the coding region with LoxP recombination sites ( Figure 1a ). In contrast to the null mutation (Sterneck et al., 1997 ) the conditional null allele was transmitted at Mendelian frequency, and C/EBPb fl/fl female mice were fertile. Furthermore, Northern analysis showed that the gene manipulations did not affect C/EBPb mRNA levels in various organs (data not shown). To confirm recombination competence of the targeted locus in vivo, the mice were mated to b-actinCre transgenic mice (Ma et al., 2003) and the genomic DNA from offspring was analysed for the predicted recombination events (Figure 1b ). Complete deletion of both the C/EBPb coding region and the neo gene were observed in the presence of b-actin-Cre. Removal of only the C/EBPb or the neo gene alone by virtue of the center LoxP site was not observed in these experiments (also confirmed by PCR analysis, not shown).
To achieve keratinocyte-specific ablation, the C/ EBPb fl/fl mice were crossed with K5-Cre transgenic mice, in which Cre recombinase expression is directed to the epidermis and other stratified epithelia by the keratin 5 promoter (Ramirez et al., 2004) . As shown in Figure 2a , C/EBPb protein was not detected in the epidermis of K5-Cre;C/EBPb fl/fl mice (faster mobility band in epidermis is non specific) but was present at normal levels in the other organs examined. Furthermore, K5-Cre; C/EBPb fl/fl females were fertile and lactation competent, indicating that ovarian and mammary gland defects present in C/EBPb À/À mice (Sterneck et al., 1997; Robinson et al., 1998) did not occur in the K5-Cre; C/EBPb fl/fl mice. In addition, K5-Cre; C/EBPb fl/fl mice exhibited normal immunostaining for C/EBPb in pulmonary alveolar macrophages of lung sections histological sections (data not shown) and no cases of splenomegaly (0/19), which is due to elevated IL-6 levels in C/EBPb null mice (Screpanti et al., 1996) were observed in K5-Cre;C/EBPb fl/fl mice. To further examine the efficiency of Cre-induced recombination within the epidermis, we conducted immunohistochemical staining for C/EBPb. In wild-type mouse skin, C/EBPb staining was observed in the nuclei of cells of the epidermis, hair follicles, and sebaceous glands (Figure 2b ). In contrast, C/EBPb was not detected in the epidermis, hair follicles, and sebaceous glands of K5-Cre;C/EBPb fl/fl mouse skin (Figure 2c ). Epithelial cells of these structures are considered to be derived from a pluripotent K5 expressing stem cell. Thus the staining pattern in K5-Cre;C/EBPb fl/fl mice suggests that the deletion of C/EBPb occurred in epidermal stem cells, the putative target cells for skin carcinogenesis.
To determine the response to two-stage skin carcinogenesis, K5-Cre;C/EBPb fl/fl mice and controls consisting of K5-Cre, C/EBPb fl/fl and wild-type mice were treated with DMBA followed by thrice weekly treatment with the tumor promoter, 12-O-tetradecanylphobol-13-acetate (TPA). As shown in Figure 3a , all three control groups displayed a 100% tumor incidence and a tumor multiplicity of B18 squamous papillomas/mouse. In contrast, K5-Cre;C/EBPb fl/fl mice did not develop any tumors. Similar results were obtained in an independent repeat experiment (data not shown). These results demonstrate that keratinocyte-specific ablation of C/ EBPb is sufficient to confer complete resistance to DMBA-induced skin tumorigenesis.
To determine if reduced keratinocyte survival, as previously observed in C/EBPb À/À mice, is associated with the resistance phenotype, apoptotic cells were scored in DMBA-treated skins. As shown in Figure 3b , both K5-Cre and K5-Cre;C/EBPb fl/fl mice displayed elevated basal levels of apoptosis in acetone vehicle treated epidermis (similar to untreated epidermis, data not shown) indicating that Cre expression alone causes keratinocyte apoptosis. However, unlike DMBA-treated K5-Cre;C/EBPb fl/fl mice, K5-Cre keratinocytes did not display a large net increase in apoptosis in response to DMBA treatment. DMBA-treated K5-Cre;C/EBPb fl/fl mice displayed a 9-to 13-fold net increase in the number of apoptotic basal keratinocytes compared to DMBAtreated C/EBPb fl/fl , K5-Cre or wild-type mice. Similar results were obtained with deoxynucleotidyltransferasemediated dUTP nick end labeling (TUNEL) staining (data not shown). These results demonstrate that a keratinocyte-intrinsic role of C/EBPb is critical for cell survival subsequent to DMBA treatment.
C/EBP proteins must undergo dimerization for DNA binding and promoter activation. As a result of the high degree of conservation in their bZIP domains, C/EBP family members form both homodimers and heterodimers (Rask et al., 2000) . C/EBPd, another member of the C/EBP family, is upregulated in mouse skin papillomas and squamous cell carcinomas (Kim and Fischer, 1998) . On the other hand, C/EBPd might act as a tumor suppressor by virtue of its role in genome maintenance (Huang et al., 2004) . To determine whether the resistance to skin tumorigenesis is a property shared with other C/EBP knockout mice and to determine whether C/EBPd has a role in skin tumorigeneis perhaps as a homodimer or as a hererodimer with C/EBPb, we conducted skin tumorigenesis studies in C/EBPd À/À mice. As shown in Figure 4 , the response of C/EBPd À/À mice was indistinguishable from that of wild-type mice in both tumor incidence and multiplicity. Similar results were obtained with N-methyl-N 0 -nitro-N-nitrosoguanidine (MNNG)/TPA treatment (data not shown). These data demonstrate that C/EBPd does not have a role in skin tumor development. This result along with earlier studies demonstrating that C/EBPa protein levels are greatly diminished in squamous papillomas, squamous carcinomas, and squamous cell carcinoma cell lines while C/EBPb protein levels are retained (Shim et al., 2005) support a unique role of C/EBPb among the C/EBP family in skin tumorigenesis.
Taken together, our results firmly establish an intrinsic keratinocyte function for C/EBPb in cell survival and mouse skin tumorigenesis. C/EBPb also functions as a prosurvival factor in myc/Ras transformed macrophages in vitro (Wessells et al., 2004) and in Wilms tumor cells (Li et al., 2005) . In an attempt to characterize the in vitro role of C/EBPb in keratinocytes survival, we previously treated primary keratinocytes isolated from C/EBPb À/À and wild-type mice with various carcinogens or transfected/infected these primary 0 side of the gene was screened by a probe external to the targeting vector (P5 0 ) that detects the conversion of a 4.5 kb EcoRI fragment into 2.5 kb and, at the 3 0 side, a probe (P3 0 ) that detects the alteration of a 7.0 kb BamHI fragment into an 8.5 kb fragment. Correctly targeted ES cells were obtained at a frequency of 1/39 and used to generate heterozygous mutant mice as described (Tessarollo, 2001) . Boxed arrowheads indicate LoxP recognition sites; TK, pGK-thymidine kinase cassettes, neo, neomycin resistance gene. The subjects used in this study were of mixed 129S1 and C57BL/6 strain background. (b) Diagram of potential recombination events in the presence of cre recombinase, and Southern blot analysis with the indicated probe of XbaI digested genomic DNA from mice with the indicated genotypes (' þ cre' indicates b-actin-cre transgenic). B, BamHI; X, XbaI; N, NotI; R, EcoRI.
Conditional ablation of C/EBPb in epidermis E Sterneck et al keratinocytes with oncogenic Ras. Preliminary data indicated that in all cases C/EBPb À/À primary keratinocytes did not display an enhanced apoptotic response , and K5-Cre;C/EBPb fl/fl mice. Male K5-Cre; C/EBPb fl/ þ and female C/EBPb fl/ þ mice were mated to generate the subjects which were genotyped using the following PCR primers; Floxed allele, 5 0 -GAGCCACCGCGTCCTCCAGC-3 0 and 5 0 -GGTCGGTGCGCGTCATTGCC-3 0 ; Cre allele, 5 0 -CGATG CAA CGAGTGATGAGGTTC-3 0 and 5 0 -CAACTACGGCCACTTG CACG-3 0 . Epidermis was removed from the dermis as described (Oh and Smart, 1998) and all organs/tissues were homogenized in RIPA buffer containing 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, pH 7.4, 1 mM PMSF, 1 mM SOV, 1 Â GIBCO complete protease inhibitor cocktail. Samples (20 mg) were separated by SDS-PAGE and western analysis was conducted as described (Zhu et al., 1999) . (b) Immunohistochemical staining for C/EBPb in skin of wild type and (c) K5-Cre;C/EBPb fl/fl mice. Mouse skins samples were frozen in OCT compound and frozen 5 mm sections were immunohistohistochemically stained using C/EBPb antibody (1:25000) (Santa Cruz C-19) as described (Oh and Smart, 1998) . HF --hair follicle, E -epidermis, and SG -sebaceous gland. , and K5-Cre;C/EBPb fl/fl mice (6-8 weeks old, six to eight mice per group) were initiated with a single dose of 200 nmol DMBA/200 ml acetone, followed 1 week late with thrice weekly treatment with 5 nmol 12-O-tetradecanoylphorbol-13-acetate (TPA)/200 ml acetone. All experiments were conducted in compliance with institutional guidelines. (b) Apoptosis in DMBA treated skin. Mice (three mice/group) were treated with 200 nmol DMBA/ 200 ml acetone or with acetone alone. Dorsal skins were collected 24 h after treatment and fixed in 10% neutral buffered formalin. The number of apoptotic keratinocytes/cm length of epidermis was determined as described (Zhu et al., 2002) . Interfollicular keratinocytes were scored from three H&E stained sections (B1.5 cm length)/mouse using the following criteria; presence of dark pyknotic nuclei, cytoplasmic eosinophilia and the absence of cellular contacts. Data are expressed as mean7s.d. of three mice. * significantly different from all other DMBA-treated groups (Po0.01) as determined by Student's t test.
Conditional ablation of C/EBPb in epidermis E Sterneck et al compared to wild-type keratinocytes (unpublished results). Since our current results eliminate the possibility of a systemic effect of C/EBPb as an explanation for the altered apoptotic skin phenotype in vivo and for the lack of an apoptotic phenotype in isolated keratinocytes, the DMBA-induced increase in keratinocytes apoptosis in skin may require the in vivo organizational structure of the epidermis. Thus, efforts to delineate the mechanism(s) of resistance to tumorigenesis and increased apoptosis in the absence of C/EBPb can now be focused directly on the keratinocyte as well as the organizational structure of the skin. From a cancer therapy perspective, it will be of interest to determine whether blocking C/EBPb function in a pre-existing tumor will result in apoptosis and subsequent tumor regression. Importantly, the conditional C/EBPb fl/fl mouse model introduced here, can now be used to assess the effect of C/EBPb deletion at various stages of tumor development, and thus address the potential of C/EBPb as a therapeutic target in skin as well as other target organs. Conditional ablation of C/EBPb in epidermis E Sterneck et al
